Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Salazar

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
Neuroendocrinology|October 16, 2007
Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinomaUrsula Plöckinger, Anne Couvelard, Massimo Falconi, et al.
Journal of Pain and Symptom Management|February 11, 2026
Early Supportive vs Standard Care in Phase I Cancer Trials: A Randomized Controlled TrialAnna Casellas-Grau, Claudia Cruz-Sequeiros, Sílvia Sala-Suñé, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2014
Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies: a nonrandomized, open-label, phase II trialCarlos R Becerra, Ramon Salazar, Rocio Garcia-Carbonero, et al.
Journal for Immunotherapy of Cancer|January 30, 2019
A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)Jean-Pascal Machiels, Ramon Salazar, Sylvie Rottey, et al.
The Journal of Pathology|August 29, 2012
A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequencySun Tian, Paul Roepman, Vlad Popovici, et al.
Journal for Immunotherapy of Cancer|September 20, 2017
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resectionRocio Garcia-Carbonero, Ramon Salazar, Ignacio Duran, et al.
JAMA Oncology|January 23, 2016
DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical TrialValérie Boige, Marc Vincent, Philippe Alexandre, et al.
Brazilian Oral Research|February 14, 2019
Influence of chlorhexidine and zinc oxide in calcium hydroxide pastes on pH changes in external root surfaceThiago Farias Rocha Lima, Juliane Fabrício Ascendino, Isabelly de Oliveira Cavalcante, et al.
Neuroendocrinology|August 29, 2018
Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine NeoplasmsJaume Capdevila, Lisa Bodei, Philippa Davies, et al.
BMC Cancer|April 18, 2015
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancerMargarita García, Mercedes Martinez-Villacampa, Cristina Santos, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Neuroendocrinology|October 16, 2007
Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinomaUrsula Plöckinger, Anne Couvelard, Massimo Falconi, et al.
Journal of Pain and Symptom Management|February 11, 2026
Early Supportive vs Standard Care in Phase I Cancer Trials: A Randomized Controlled TrialAnna Casellas-Grau, Claudia Cruz-Sequeiros, Sílvia Sala-Suñé, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2014
Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies: a nonrandomized, open-label, phase II trialCarlos R Becerra, Ramon Salazar, Rocio Garcia-Carbonero, et al.
Journal for Immunotherapy of Cancer|January 30, 2019
A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)Jean-Pascal Machiels, Ramon Salazar, Sylvie Rottey, et al.
The Journal of Pathology|August 29, 2012
A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequencySun Tian, Paul Roepman, Vlad Popovici, et al.
Journal for Immunotherapy of Cancer|September 20, 2017
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resectionRocio Garcia-Carbonero, Ramon Salazar, Ignacio Duran, et al.
JAMA Oncology|January 23, 2016
DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical TrialValérie Boige, Marc Vincent, Philippe Alexandre, et al.
Brazilian Oral Research|February 14, 2019
Influence of chlorhexidine and zinc oxide in calcium hydroxide pastes on pH changes in external root surfaceThiago Farias Rocha Lima, Juliane Fabrício Ascendino, Isabelly de Oliveira Cavalcante, et al.
Neuroendocrinology|August 29, 2018
Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine NeoplasmsJaume Capdevila, Lisa Bodei, Philippa Davies, et al.
BMC Cancer|April 18, 2015
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancerMargarita García, Mercedes Martinez-Villacampa, Cristina Santos, et al.
Pageof 14